CVI Holdings’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-37,863
Closed -$3K – 937
2022
Q2
$3K Hold
37,863
– – ﹤0.01% 901
2022
Q1
$7K Sell
37,863
-3,803
-9% -$1.65K ﹤0.01% 900
2021
Q4
$24K Hold
41,666
– – ﹤0.01% 872
2021
Q3
$26K Hold
41,666
– – ﹤0.01% 828
2021
Q2
$46K Hold
41,666
– – ﹤0.01% 707
2021
Q1
$37K Buy
+41,666
New +$70.5K ﹤0.01% 573

Other funds holding FLACW

CVI Holdings's FLACW Position: Q3 2022 in Review

CVI Holdings sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 37,863 shares — an estimated $3K sold.

CVI Holdings first reported a position in FLACW in Q1 2021 and held it in 6 quarters. The position peaked at $46K in Q2 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

  • CVI Holdings reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
  • CVI Holdings sold 37,863 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $3K.
  • CVI Holdings first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
  • CVI Holdings's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $46K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on CVI Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.